DalsnaFinance › IPOs › Gain Therapeutics › IPO
Gain Therapeutics, Inc. completed its initial public offering on NASDAQ on March 18, 2021, pricing at $11.00 a share.
| Ticker | GANX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 18, 2021 |
| Offering price | $11.00 |
| Shares offered | 3,636,364 |
| Total raised | $40M |
Gain Therapeutics, Inc. sold 3,636,364 shares at $11.00 each on NASDAQ. Multiplied out, that is $40 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $40 million total recorded for the deal.
Gain Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Gain Therapeutics, Inc.. This page is general information, not investment advice.